Back

C.H. (Henri) van Werkhoven

Assistant Professor

  • Department of Epidemiology
  • Julius Center Research Program Infectious Diseases

C.H. (Henri) van Werkhoven

Research Programs

Research Output (53)

Impact of antimicrobial de-escalation on mortality: a literature review of study methodology and recommendations for observational studies

Van Heijl Inger, Schweitzer Valentijn A., van der Linden Paul D., Bonten Marc J. M., Van Werkhoven Cornelis H. 3 mei 2020, In: Expert review of Anti-infective Therapy. 18 , p. 405-413 9 p.

Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1):a multicenter stepped-wedge cluster randomized controlled trial

Mackay T M, Smits F J, Latenstein A E J, Bogte A, Bonsing B A, Bos H, Bosscha K, Brosens L A A, Hol L, Busch O R C, Creemers G J, Curvers W L, den Dulk M, van Dieren S, van Driel L M J W, Festen S, van Geenen E J M, van der Geest L G, de Groot D J A, de Groot J W B, Haj Mohammad N, Haberkorn B C M, Haver J T, van der Harst E, Hemmink G J M, de Hingh I H, Hoge C, Homs M Y V, van Huijgevoort N C, Jacobs M A J M, Kerver E D, Liem M S L, Los M, Lubbinge H, Luelmo S A C, de Meijer V E, Mekenkamp L, Molenaar I Q, van Oijen M G H, Patijn G A, Quispel R, van Rijssen L B, Römkens T E H, van Santvoort H C, Schreinemakers J M J, Schut H, Seerden T, Verdonk R C, Wessels F J, van Werkhoven C H, 16 apr 2020, In: Trials. 21 18 p.

Cost-effectiveness of selective digestive decontamination (SDD) versus selective oropharyngeal decontamination (SOD) in intensive care units with low levels of antimicrobial resistance:an individual patient data meta-analysis

van Hout Denise, Plantinga Nienke L, Bruijning-Verhagen Patricia C, Oostdijk Evelien A N, de Smet Anne Marie G A, de Wit G Ardine, Bonten Marc J M, van Werkhoven Cornelis H 6 sep 2019, In: BMJ Open. 9

Effectiveness of extended- versus normal-release nitrofurantoin for cystitis:an instrumental variable analysis

Ten Doesschate Thijs, Groenwold Rolf H H, Bonten Marc J M, van Werkhoven Cornelis H 29 aug 2019, In: The Journal of antimicrobial chemotherapy. 74 , p. 3337-3343 7 p.

A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands

Gessner Bradford D., Jiang Qin, Van Werkhoven Cornelis H., Sings Heather L., Webber Chris, Scott Daniel, Gruber William C., Grobbee Diederick E., Bonten Marc J. M., Jodar Luis 9 jul 2019, In: Vaccine. 37 , p. 4147-4154 8 p.

Burden of disease in children with respiratory tract infections in primary care: diary-based cohort study.

Schot M. J. C., Dekker A. R. J., van Werkhoven C. H., van der Velden A. W., Cals J. W. L., Broekhuizen B. D. L., Hopstaken R. M., de Wit N. J., Verheij T. J. M. 5 jun 2019, In: Family Practice. 36 , p. 723-729 7 p.

How fluoroquinolones poison the neighbourhood

van Werkhoven Cornelis H., Bootsma Martin, Bonten Marc apr 2019, In: The Lancet Infectious Diseases. 19 , p. 347-348 2 p.

Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia:Post-hoc analysis of a cluster-randomized trial

Postma Douwe F., Spitoni Cristian, Van Werkhoven Cornelis H., Van Elden Leontine J.R., Oosterheert Jan Jelrik, Bonten Marc J.M. 7 jan 2019, In: BMC Infectious Diseases. 19

Confounding by indication of the safety of de-escalation in community-acquired pneumonia:A simulation study embedded in a prospective cohort

van Heijl Inger, Schweitzer Valentijn A, Boel C H Edwin, Oosterheert Jan Jelrik, Huijts Susanne M, Dorigo-Zetsma Wendelien, van der Linden Paul D, Bonten Marc J M, van Werkhoven Cornelis H 1 jan 2019, In: PLoS ONE. 14

Vaccines to Prevent Pneumococcal Community-Acquired Pneumonia

van Werkhoven Cornelis H., Huijts Susanne M. 1 dec 2018, In: Clinics in chest medicine. 39 , p. 733-752 20 p.

All Research Output (53)